Michelle Kirschner, Managing Director of the International Cancer Rehabilitation Foundation, Clinical Lead and Medical Advisory Board Chairman at OneVillage, shared on LinkedIn:
“As cancer survivorship continues to grow, clinicians are increasingly encountering the delayed and often devastating effects of radiation-induced fibrosis.
Unfortunately, a lack of awareness and understanding surrounding the assessment and treatment of Radiation Fibrosis Syndrome (RFS) has contributed to significant and potentially preventable disability among cancer survivors.
Radiation fibrosis can present years after treatment and lead to a wide range of functional impairments, including:
- Head Drop Syndrome
- Trismus and jaw dysfunction
- Dysphagia and swallowing impairment
- Neck and shoulder pain with restricted mobility
- Cervical dystonia and postural abnormalities
- Shoulder dysfunction following breast or head and neck cancer treatment
- Lymphedema
- Chest wall restriction and respiratory limitations
- Trunk and spinal mobility deficits
- Gait and balance impairments
- Soft tissue contractures
- Progressive weakness and deconditioning
- Neuropathic pain and sensory changes
- Limitations in activities of daily living, work, and community participation
For many survivors, these impairments become accepted as unavoidable consequences of treatment when, in reality, earlier recognition and evidence-based rehabilitation interventions may significantly improve function and quality of life.
Can we do better?
Join nationally recognized leaders in cancer rehabilitation for an advanced clinical discussion focused on the evaluation and management of Radiation Fibrosis Syndrome.
This webinar will review the latest evidence regarding radiation-induced fibrosis, functional assessment, rehabilitation interventions, multidisciplinary treatment approaches, and emerging research designed to bridge the gap between science and clinical practice.
- International Cancer Rehabilitation Foundation’s Advances in Oncology Rehabilitation: Professional Education Series
- Radiation Fibrosis Syndrome: Clinical Evaluation, Treatment Strategies, and Emerging Research
Event Information
- Date: Wednesday, November 4, 2026
- Time: 6:00 PM – 7:00 PM EST
- Location: Virtual
- Cost: Free
Help us advance awareness, early identification, and effective treatment of Radiation Fibrosis Syndrome. Together, we can improve functional outcomes and quality of life for cancer survivors.
The question isn’t whether survivors are experiencing these impairments.
The question is: Can we do better?
Also consider becoming a free professional member of the ICRF“
Other articles about Michelle Kirschner on OncoDaily.